Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications
Conditions
Interventions
Intervention1: Standard therapy with zinc (oral zinc sulphate 20mg daily for 12 weeks): Standard therapy with zinc (oral zinc sulphate 20mg daily for 12 weeks)
Control Intervention1: Standard therapy
Sponsors
JIPMER Intramural Research Grant
Eligibility
Inclusion criteria
Inclusion criteria: Type 1diabetes mellitus children diagnosed as per WHO criteria aged 3 to 18 years with minimum duration from diagnosis of 6 months
Exclusion criteria
Exclusion criteria: Patients who were treated with zinc for other illnesses in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of daily zinc (20mg) supplementation on change in HbA1c level.Timepoint: 4 weeks, 8 weeks, 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)To analyze the effect of zinc supplementation on the antioxidant activity 2)To analyze the effect of zinc supplementation on autoantibodies in Type 1 DM 3)To analyze the effect of zinc supplementation on c-peptide levels 4)To analyze the effect of zinc supplementation on lipid profile Timepoint: 4 weeks, 8 weeks, 12 weeks | — |
Countries
India
Contacts
Public ContactVijayalaxmi Yeresheeme
JIPMER, Puducherry
Outcome results
None listed